Sign in
Not yet taking people in United StatesNo phase

Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis

Key facts

Who runs it
Ambrish Patel
Where
Columbus, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
20 people, planned
Started
Oct 2026
Expected to end
Dec 2029
Type of study
Observational, 2 groups
Treatments tested
  • Serum blood samples for serum biomarkers of immune response
Record updated
6 August 2026

Who can take part

Age
0 years to 99 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Any patient undergoing a posterior spinal fusion, regardless of age (birth to adult)
  • any patient with a diagnosis of idiopathic or neuromuscular scoliosis

Who cannot take part

  • Patient taking immunomodulators (monoclonal antibodies, chemotherapeutic agents)
  • chronic steroid use

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 0 and 99 years old?

Where in United States

  • Nationwide Children's HospitalColumbus, United StatesContact: Catherine RothNot yet recruiting

About the trial

What the trial wants to find out

The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients with idiopathic scoliosis who undergo the same procedure. This will be accomplished using serum biomarkers of immune response. Anecdotally, it appears that patients with neuromuscular scoliosis have more fluid resuscitation needs compared to patients with idiopathic scoliosis. The proposed hypothesis of this observation is that patients with neuromuscular scoliosis have a more profound immune response compared to patients with idiopathic scoliosis, which leads to a more robust systematic inflammatory response syndrome.

The 2 groups in the trial

  • Neuromuscular scoliosis

    Patients with neuromuscular scoliosis undergoing posterior spinal fusion

    Treatment: Serum blood samples for serum biomarkers of immune response

  • Idiopathic scoliosis

    Patients with idiopathic scoliosis undergoing posterior spinal fusion

    Treatment: Serum blood samples for serum biomarkers of immune response

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Immune Response Following Posterior Spinal Fusion in Patients With Idiopathic vs. Neuromuscular Scoliosis
Criteria questions
Built from NCT07734467, who can take part
Record updated
6 August 2026